BACKGROUND
Comprehensive genomic technologies such as genome sequencing have enabled timely diagnoses and improved patient outcomes.
• However, diagnosis for rare diseases relies heavily on phenotypic assessment, specific clinical guidelines for genetic testing, and overall access to care
• Multiple molecular diagnoses are made in over 7% of patients having WGS
We present a patient case report that highlights the complexities and implications of the evolving genomic medicine landscape.
